<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2025-09-30</publicationDate>
    
        <volume>18</volume>
        <issue>3</issue>

 
    <startPage>2070</startPage>
    <endPage>2082</endPage>

	 
      <doi>10.13005/bpj/3238</doi>
        <publisherRecordId>67254</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Molecular Modelling Study of Cofilin Dimer Inhibitors in Cognitive Decline</title>

    <authors>
	 


      <author>
       <name>Magesh Mohan</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Renukadevi Jeyavelkumaran</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Vijayakumar Balakrishnan</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Sanjay Valliappan</name>

		
	<affiliationId>1</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Pharmaceutical Chemistry, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Pharmaceutical Chemistry, Grace College of Pharmacy, Kerala University of Health Sciences, Palakkad, India</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Cofilin is crucial for the maintenance of neuronal architecture, synaptic plasticity, and intracellular transport. The dimerization of cofilin under oxidative stress contributes to the formation of cofilin-actin rods, which severely interfere with synaptic signaling, axonal transport, and intracellular trafficking. Such pathological changes are hallmarks of various neurodegenerative diseases. This study aimed at the identification of small-molecule inhibitors targeting cofilin dimerization, which could restore its monomeric, actin-severing state. Eighteen candidate compounds were screened using molecular docking and molecular dynamics simulations to assess their potential to disrupt the dimerization interface. Asiaticoside, Actinorhodin, and Granatin A demonstrated the most favorable binding affinities, with Asiaticoside emerging as the strongest inhibitor (-7.3 kcal/mol). Derived from Bacopa monnieri (Brahmi), Asiaticoside displayed stable binding to critical dimerization residues, as confirmed by molecular dynamics simulations. These simulations showed a stable protein-ligand complex with minimal structural fluctuations, a consistent hydrogen bond network, and strong electrostatic and hydrophobic interactions. This work highlights the therapeutic potential for targeting cofilin dimerization to restore actin filament dynamics and ameliorate neurodegenerative disease-associated cytoskeletal dysfunction. The overall findings suggest Asiaticoside to be a promising lead compound, with experimental validation and optimization being necessary to enhance the translational application in the treatment of neurodegenerative disorders.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol18no3/molecular-modelling-study-of-cofilin-dimer-inhibitors-in-cognitive-decline/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Asiaticoside</keyword>
      

      
        <keyword> Cofilin dimer inhibitors</keyword>
      

      
        <keyword> Cognitive decline</keyword>
      

      
        <keyword> GROMACS</keyword>
      

      
        <keyword> MD simulation</keyword>
      
</keywords>
  </record>
</records>